Horizon Science has welcomed acclaimed biologist Professor David Sinclair to its impressive Board of Directors. Coinciding with the appointment of new Chairman, Peter Amon, plus Dr. Gunnar Weikert and Dr. Ajai Puri as Directors, the emerging bio-tech company is demonstrating a clear commitment to continuing to achieve scientific and commercial success.
A Professor at Harvard Medical School, Sinclair is recognized for his advances in understanding the role of sirtuins in disease and aging and pharmacological agents such as resveratrol. Notably, Sinclair co-founded pharmaceutical company Sirtris in 2004 to develop medicines for diseases of aging which sold to GlaxoSmithKline in 2008 for $720m.
Ashok Dhanrajgir, CEO believes the senior additions to the team will enable Horizon Science to achieve its goals of addressing global health issues through the application of natural science.
"David, Peter, Gunnar and Ajai bring a depth of experience across food and pharmaceutical to our business. Their commercial acumen and networks will increase the rate at which Horizon Science’s patented technologies are licensed by food and healthcare manufacturers," he said.
Peter Amon joined forces with Horizon Science following 20 years experience managing iconic global brands like Knorr, Lipton and Philadelphia and having worked in various leadership roles for Unilever and Kraft Foods in Europe, the US and Asia.
"The opportunity to join an organization that offers best-in-class leadership and technology and that has already proved its competitive edge with a commercial success like LoGiCane inspires me," said Amon.
"Securing David Sinclair to contribute to our Board of Directors and our Scientific Advisory Board is a significant achievement which will generate interest from manufacturers and the industry," he concluded.
Founder of Inventages Dr. Gunnar Weikert comes from a strong background in life science with proven capability in closing bio-technology deals with major pharmaceuticals. His appointment underscores the commitment and support that Horizon Science continues to enjoy from its lead investor.
Food science specialist Dr. Ajai Puri brings strong medical nutrition experience to the company, based on his 22 year career with The Coca-Cola Company in the US, in addition to leadership in R&D for organizations within the nutrition sector.
Horizon Science’s Board of Directors now totals seven. In addition to CEO Ashok Dhanrajgir and the four newly appointed Board members, it includes the co-founder of BioPacificVentures Dr. Andrew Kelly and corporate advisor Ross Dobinson.
With commercial headquarters in Melbourne, Victoria, Horizon Science’s most high profile achievement to date is the launch of LoGiCane, the world’s first low GI sugar, in 2009. Certified by the Glycemic Index Foundation, LoGiCane is distributed under license through Sugar Australia.
Most recently, Horizon Science has made significant advances with trials of a patented weight management extract, which has potential to impact growing obesity rates. Strong scientific studies confirming fat and weight reduction have already been achieved in animal trials.